Pharmaceutical companies in 4.0 & DMS era: Take it or leave it?
As the term “4.0” (or “fourth industrial revolution”) becomes more popular, devices can “talk” to each other, separate software programmes are integrated, data are automatically synthesized and information comes “rushing” to users (according to predefined conditions); our approach to business management on technological platforms must obviously change. Pharmaceutical companies are no exception; in fact, they […]